Mechanism of Action of an Interleukin (IL)–23 Inhibitor Monoclonal Antibody in Moderate to Severe Plaque Psoriasis and Active Psoriatic Arthritis
Sponsored by Janssen Biotech, Inc.
This disease education update from Janssen provides an overview of an interleukin (IL)-23 inhibitor.
Jun 01, 2023